Display options
Share it on

J Cardiothorac Vasc Anesth. 2021 Feb;35(2):378-388. doi: 10.1053/j.jvca.2020.07.017. Epub 2020 Jul 30.

The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma.

Journal of cardiothoracic and vascular anesthesia

Theresa A Gelzinis

Affiliations

  1. University of Pittsburgh, Pittsburgh, PA. Electronic address: [email protected].

PMID: 32798169 DOI: 10.1053/j.jvca.2020.07.017

Abstract

Malignant pleural mesothelioma is a rare aggressive cancer, with insidious growth, and is associated with poor outcomes that have not improved over the years. A task force made up of members of the European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for Radiotherapy and Oncology (ESTRO) societies, who are experts in the field of malignant mesothelioma, reviewed the literature from 2009 to 2018 to update the 2009 guidelines concerning epidemiology, diagnosis, staging, and treatment, including surgical, radiotherapy, and medical management, as well as palliative care to provide the best evidence-based recommendations for this patient population.

Copyright © 2020 Elsevier Inc. All rights reserved.

MeSH terms

Publication Types